Last reviewed · How we verify
Fluzone Quadrivalent vaccine, No Preservative — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Fluzone Quadrivalent vaccine, No Preservative (Fluzone Quadrivalent vaccine, No Preservative) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fluzone Quadrivalent vaccine, No Preservative TARGET | Fluzone Quadrivalent vaccine, No Preservative | Sanofi Pasteur, a Sanofi Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fluzone Quadrivalent vaccine, No Preservative CI watch — RSS
- Fluzone Quadrivalent vaccine, No Preservative CI watch — Atom
- Fluzone Quadrivalent vaccine, No Preservative CI watch — JSON
- Fluzone Quadrivalent vaccine, No Preservative alone — RSS
Cite this brief
Drug Landscape (2026). Fluzone Quadrivalent vaccine, No Preservative — Competitive Intelligence Brief. https://druglandscape.com/ci/fluzone-quadrivalent-vaccine-no-preservative. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab